Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
Rhea-AI Summary
Zimmer Biomet (NYSE: ZBH) announced management will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m. PT (11:40 a.m. ET). A live audio webcast will be available on the company Investor Relations website and for replay after the session.
Positive
- None.
Negative
- None.
News Market Reaction – ZBH
In the May 6 session, ZBH declined 0.22%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 28 | Q1 2026 earnings | Positive | -10.6% | Stronger Q1 2026 sales, earnings and cash flow with raised guidance. |
| Apr 28 | CFO transition | Negative | -10.6% | CFO departure and interim CFO appointment announced alongside leadership search. |
| Apr 9 | Earnings call setup | Neutral | +0.0% | Announcement of webcast and conference call for Q1 2026 results. |
| Apr 7 | Leadership appointment | Positive | +0.4% | Appointment of new Chief Science, Technology and Medical Affairs Officer. |
| Feb 25 | Conference data, products | Positive | -0.0% | Plan to present new data and showcase innovations at AAOS 2026. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent ZBH news has included strong Q1 2026 results and leadership changes. Earnings and CFO transition on Apr 28 coincided with a sharp -10.57% move, while prior conference, innovation, and appointment headlines saw minimal price impact, suggesting occasional sharp repricing around financial/leadership events but muted moves on routine updates.
Over the last few months, ZBH has reported stronger Q1 2026 financials with higher net sales, earnings and cash flow, alongside leadership changes including a CFO transition and a new Chief Science, Technology and Medical Affairs Officer. The stock moved -10.57% after the Q1 earnings and CFO news on Apr 28, contrasting with near-flat reactions to an earnings call webcast announcement, innovation showcases at AAOS 2026, and the April leadership appointment. Today’s conference-participation news fits the pattern of routine investor-relations visibility rather than a new financial or clinical catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the fireside chat.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts:
| |
Media | Investors |
Troy Kirkpatrick | David DeMartino |
614-284-1926 | 646-531-6115 |
Kirsten Fallon | Zach Weiner |
781-779-5561 | 908-591-6955 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-the-bofa-securities-2026-health-care-conference-302763299.html
SOURCE Zimmer Biomet Holdings, Inc.